Ftse Mib
33.736,40
0,00%
DAX
17.896,50
-0,14%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.532,91
0,70%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Apellis Pharmaceuticals Inc (APLS) Apellis Pharmaceuticals Inc (APLS) Notizie

Apellis Pharmaceuticals Inc

APLS
47,49
1,44 (3,13%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202413:00GLOBEApellis Announces 11 Oral Presentations at the Association..
26/4/202413:15GLOBEApellis Announces Pegcetacoplan MAA Review Has Been Reset to..
23/4/202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on May 7,..
04/4/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01/4/202413:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the 23rd..
11/3/202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202412:00GLOBEApellis Appoints Leading Expert Dr. Philip Ferrone as Chief..
08/3/202422:10EDGAR2Form 144 - Report of proposed sale of securities
08/3/202413:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
05/3/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202422:25EDGAR2Form 144 - Report of proposed sale of securities
01/3/202419:37EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27/2/202413:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202413:30EDGAR2Form 8-K - Current report
27/2/202413:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
27/2/202413:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202413:00GLOBEApellis Pharmaceuticals to Present at Upcoming Investor..
20/2/202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
14/2/202423:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202421:46EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:43EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:28EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:27EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:22EDGAR2Form 144 - Report of proposed sale of securities
12/2/202421:19EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
31/1/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202416:50EDGAR2Form 144 - Report of proposed sale of securities
30/1/202416:04EDGAR2Form 144 - Report of proposed sale of securities
29/1/202421:22EDGAR2Form 144 - Report of proposed sale of securities
29/1/202421:21EDGAR2Form 144 - Report of proposed sale of securities
29/1/202421:21EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 46,62 Min: 46,10 Max: 47,74
Chiusura: 46,05

La tua Cronologia

NASDAQ
APLS
Apellis Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network